Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$10.8M Buy
615,587
+86,038
+16% +$1.65M 0.01% 922
2025
Q4
$11.8M Sell
529,549
-24,834
-4% -$593K 0.01% 883
2025
Q3
$15.1M Buy
554,383
+2,112
+0.4% +$63.8K 0.01% 829
2025
Q2
$16M Buy
552,271
+1,381
+0.3% +$39.2K 0.01% 759
2025
Q1
$15.8M Buy
550,890
+115,342
+26% +$4.36M 0.01% 659
2024
Q4
$19.5M Buy
435,548
+134,867
+45% +$6.37M 0.02% 617
2024
Q3
$13.3M Buy
300,681
+5,478
+2% +$224K 0.01% 669
2024
Q2
$11.4M Sell
295,203
-31,142
-10% -$1.28M 0.01% 606
2024
Q1
$16M Buy
326,345
+15,803
+5% +$758K 0.01% 559
2023
Q4
$15M Buy
310,542
+158,253
+104% +$7.05M 0.02% 471
2023
Q3
$6.18M Sell
152,289
-61,153
-29% -$2.42M 0.01% 624
2023
Q2
$8.44M Sell
213,442
-17,223
-7% -$624K 0.01% 537
2023
Q1
$9.39M Buy
+230,665
New +$8.48M 0.01% 563
2021
Q4
Sell
-18,287
Closed -$1.33M 1492
2021
Q3
$1.33M Buy
+18,287
New +$1.34M ﹤0.01% 1229
2021
Q2
Sell
-74,600
Closed -$3.21M 1952
2021
Q1
$3.21M Buy
+74,600
New +$3.69M ﹤0.01% 1370

Other funds holding DCBO

Arrowstreet Capital's DCBO Position: Q1 2026 in Review

Arrowstreet Capital increased its Docebo (DCBO) stake by 16% in Q1 2026, buying an estimated $1.65M and bringing the position to 615,587 shares worth $10.8M. The position accounts for 0.01% of the portfolio, ranked #922.

Arrowstreet Capital first reported a position in DCBO in Q1 2021 and has held it in 15 quarters since. The position peaked at $19.5M in Q4 2024. 67 funds tracked by Wall St. Rank hold DCBO as of Q1 2026.

  • Arrowstreet Capital held 615,587 shares of Docebo worth $10.8M as of Q1 2026.
  • Arrowstreet Capital bought 86,038 Docebo shares in Q1 2026, an estimated $1.65M.
  • Docebo made up 0.01% of Arrowstreet Capital's portfolio in Q1 2026, its #922 holding.
  • Arrowstreet Capital first reported a position in Docebo in Q1 2021 and has held it in 15 quarters since.
  • Arrowstreet Capital's Docebo position peaked at $19.5M in Q4 2024.
  • 67 funds tracked by Wall St. Rank held Docebo as of Q1 2026.

Based on Arrowstreet Capital's 13F filing for Q1 2026, filed 14 May 2026.